Radzisław Kordek Selected Research

Radzisław Kordek Research Topics

Disease

19	Neoplasms (Cancer) 01/2021 - 01/2002
16	Colitis 02/2022 - 03/2014
12	Inflammation (Inflammations) 11/2021 - 10/2014
11	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2005
9	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2022 - 03/2014
5	Crohn Disease (Crohn's Disease) 08/2021 - 10/2014
4	Ulcerative Colitis 08/2021 - 10/2014
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 01/2008
3	Abdominal Pain (Pain, Abdominal) 10/2015 - 03/2014
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2007 - 05/2003
2	Ulcer 01/2017 - 05/2016
2	Carcinogenesis 11/2016 - 01/2012
2	Disease Progression 06/2016 - 06/2004
1	Idiopathic Pulmonary Fibrosis 02/2022
1	Asthma (Bronchial Asthma) 02/2022
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 02/2022
1	Colonic Neoplasms (Colon Cancer) 02/2022
1	Body Weight (Weight, Body) 11/2021
1	Stomach Ulcer (Gastric Ulcer) 05/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Lymphatic Metastasis 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Colitis-Associated Neoplasms 10/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 06/2016

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2002
5	Dextran SulfateIBA 02/2022 - 05/2020
5	Peroxidase (Myeloperoxidase)IBA 08/2021 - 12/2014
5	Cladribine FDA LinkGeneric 05/2007 - 10/2002
4	Opioid Receptors (Opioid Receptor)IBA 11/2021 - 10/2014
4	Opioid Analgesics (Opioids)IBA 11/2021 - 10/2014
4	Trinitrobenzenesulfonic AcidIBA 08/2021 - 10/2014
4	Dextrans (Dextran)FDA Link 03/2021 - 10/2014
4	Drinking WaterIBA 10/2020 - 10/2014
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2007 - 10/2002
3	AcidsIBA 02/2021 - 10/2015
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2019
3	sodium sulfate (sodium bisulfate)FDA LinkGeneric 10/2020 - 10/2014
2	Progesterone FDA LinkGeneric 01/2022 - 01/2015
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2022 - 01/2015
2	Phenobarbital (Luminal)FDA Link 01/2022 - 01/2005
2	LigandsIBA 11/2021 - 01/2015
2	LipidsIBA 11/2021 - 01/2012
2	Nonesterified Fatty Acids (NEFA)IBA 11/2021 - 08/2021
2	SodiumIBA 03/2021 - 01/2017
2	Cadherins (E-Cadherin)IBA 01/2021 - 01/2007
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2019
2	Sulfonic AcidsIBA 01/2019 - 12/2014
2	Estrogen ReceptorsIBA 01/2019 - 01/2005
2	MicroRNAs (MicroRNA)IBA 01/2019 - 11/2016
2	SilverIBA 06/2017 - 01/2017
2	ParaffinIBA 11/2016 - 03/2004
2	Rituximab (Mabthera)FDA Link 08/2006 - 06/2004
2	Keratins (Keratin)IBA 01/2005 - 01/2002
1	ChitinasesIBA 02/2022
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 01/2022
1	D-Penicillamine (2,5)- EnkephalinIBA 11/2021
1	Ala(2)-MePhe(4)-Gly(5)- Enkephalin (DAGO)IBA 11/2021
1	ORALIT (ORS)IBA 11/2021
1	Naloxone (Narcan)FDA LinkGeneric 11/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 08/2021
1	GW9508IBA 08/2021
1	Bacterial AntigensIBA 08/2021
1	GSK137647IBA 08/2021
1	Diclofenac (SR 38)FDA LinkGeneric 05/2021
1	SolutionsIBA 05/2021
1	AdipoRonIBA 05/2021
1	GoldIBA 03/2021
1	CathelicidinsIBA 02/2021
1	Death Domain ReceptorsIBA 01/2021
1	Cyclin D1IBA 01/2021
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2021
1	morphiceptinIBA 10/2020
1	Hematoxylin (Haematoxylon)IBA 10/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 10/2020
1	AzoxymethaneIBA 10/2020
1	CateninsIBA 10/2020
1	Genetic Markers (Genetic Marker)IBA 01/2019
1	Codon (Codons)IBA 01/2019
1	Estrogens (Estrogen)FDA Link 01/2019
1	GTP-Binding Proteins (G-Protein)IBA 01/2019
1	TetraspaninsIBA 10/2018
1	Tamoxifen FDA LinkGeneric 10/2017
1	Growth Factor ReceptorsIBA 10/2017
1	Sulfates (Sulfates, Inorganic)IBA 01/2017
1	SuspensionsIBA 01/2017
1	HLA Antigens (Human Leukocyte Antigens)IBA 06/2016
1	HLA-G Antigens (HLA G)IBA 06/2016
1	MelatoninIBA 05/2016
1	Melatonin Receptors (Melatonin Receptor)IBA 05/2016
1	mesotocin receptorIBA 05/2016
1	Ethanol (Ethyl Alcohol)IBA 05/2016

Therapy/Procedure

7	Therapeutics 02/2022 - 01/2012
3	Drug Therapy (Chemotherapy) 01/2010 - 01/2008
2	Oral Administration 05/2021 - 03/2014
2	Neoadjuvant Therapy 01/2018 - 05/2012
2	Radiotherapy 01/2009 - 06/2004
1	Intraperitoneal Injections 10/2020